novartis - dofaq.co
Novartis pays PeptiDream $180M as radiopharma big bang continues
Fierce Biotech - 30 Apr 2024
Novartis pays PeptiDream $180M as radiopharma big bang continues ...
Morphosys says takeover by Novartis on course after report of drug safety concern
Reuters - 29 Apr 2024
Morphosys says takeover by Novartis on course after report of drug safety concern ...
New, serious safety risk related to MorphoSys' cancer drug complicates, potentially threatens, Novartis acquisition
STAT - 28 Apr 2024
New, serious safety risk related to MorphoSys' cancer drug complicates, potentially threatens, Novartis acquisition ...
Research and development
Novartis - 08 Feb 2024
Research and development ...
PeptiDream Announces Expansion of Peptide Discovery Collaboration with Novartis
Business Wire - 30 Apr 2024
PeptiDream Announces Expansion of Peptide Discovery Collaboration with Novartis ...
Novartis, Neurocrine-Takeda, Enhertu—Fierce Pharma Asia
Fierce Pharma - 26 Apr 2024
Novartis, Neurocrine-Takeda, Enhertu—Fierce Pharma Asia ...
Safety Concerns with MorphoSys’ Blood Cancer Drug Could Mar $2.9B Novartis Buy: STAT
BioSpace - 29 Apr 2024
Safety Concerns with MorphoSys’ Blood Cancer Drug Could Mar $2.9B Novartis Buy: STAT ...
Medicines for Malaria Venture and Novartis announce positive efficacy and safety data for a novel treatment for babies ...
Medicines for Malaria Venture - 24 Apr 2024
Medicines for Malaria Venture and Novartis announce positive efficacy and safety data for a novel treatment for babies ... ...
Novartis reports 25% increase in net income in Q1 2024
Pharmaceutical Technology - 24 Apr 2024
Novartis reports 25% increase in net income in Q1 2024 ...
Alexion and Novartis/Genentech start UPC's first ever biosimilar disputes
IAM - 24 Apr 2024
Alexion and Novartis/Genentech start UPC's first ever biosimilar disputes ...
Turkey vs. Zolgensma: the battle over a $2.1 million drug - SWI swissinfo.ch
SWI swissinfo.ch in English - 26 Apr 2024
Turkey vs. Zolgensma: the battle over a $2.1 million drug - SWI swissinfo.ch ...
Morphosys says Novartis takeover progressing as planned for H1 2024
XM - 29 Apr 2024
Morphosys says Novartis takeover progressing as planned for H1 2024 ...
Deciphex partners with Novartis for AI drug research
SiliconRepublic.com - 29 Apr 2024
Deciphex partners with Novartis for AI drug research ...
16-week paid leave a work-life win
The Straits Times - 29 Apr 2024
16-week paid leave a work-life win ...
Novartis Exceeds Q1 Forecasts, Boosts Outlook as Blockbuster Drug Sales Climb
Investopedia - 23 Apr 2024
Novartis Exceeds Q1 Forecasts, Boosts Outlook as Blockbuster Drug Sales Climb ...
Novartis nominates ex-BMS chief Giovanni Caforio as its next chair
Fierce Pharma - 23 Apr 2024
Novartis nominates ex-BMS chief Giovanni Caforio as its next chair ...
Novartis in Society Integrated Report
Novartis - 31 Jan 2024
Novartis in Society Integrated Report ...
Novartis accused of promoting asthma drug for preterm labor despite brain risk
Reuters - 23 Apr 2024
Novartis accused of promoting asthma drug for preterm labor despite brain risk ...
Novartis 'actively' reviewing relationships with Chinese contractors amid US biosecurity crackdown: CFO
Fierce Pharma - 23 Apr 2024
Novartis 'actively' reviewing relationships with Chinese contractors amid US biosecurity crackdown: CFO ...